Revolutionary advances in the diagnosis of vitamin D deficiency

Journal of Environmental Pathology, Toxicology and Oncology

Volumn 29, Issue 2, 2010, Pages 85-89

  Edlich, Richard F ^a   Mason, Shelley S ^b   Reddig, Jill S ^b   Gubler, K Dean ^c   Long III, William B ^d  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^b Multiple Sclerosis Research Fund   (United States)

^c LEGACY EMANUEL HOSPITAL   (United States)

^d Legacy Emmanuel Hospital   (United States)

Author keywords

Immunochemiluminometrics; Liquid chromotography tandem mass spectrometry; Radioimmunoassay; Vitamin D deficiency

Indexed keywords

25 HYDROXYVITAMIN D; COLECALCIFEROL; ERGOCALCIFEROL; VITAMIN D; 25-HYDROXYVITAMIN D;

AUTOANALYZER; AUTOIMMUNE DISEASE; CHEMOLUMINESCENCE; DIABETES MELLITUS; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DIAGNOSTIC TEST; FRACTURE; HEART INFARCTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYPERTENSION; LIQUID CHROMATOGRAPHY; MULTIPLE SCLEROSIS; NEOPLASM; OSTEOMALACIA; OSTEOPOROSIS; PERIODONTAL DISEASE; PRIORITY JOURNAL; RADIOIMMUNOASSAY; REVIEW; RICKETS; RISK FACTOR; SENSITIVITY AND SPECIFICITY; STANDARDIZATION; STROKE; TANDEM MASS SPECTROMETRY; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION; ANALOGS AND DERIVATIVES; BLOOD; LUMINESCENCE;

APOIDEA;

CHROMATOGRAPHY, LIQUID; HUMANS; LUMINESCENT MEASUREMENTS; RADIOIMMUNOASSAY; TANDEM MASS SPECTROMETRY; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 77953339778     PISSN: 07318898     EISSN: None     Source Type: Journal    
DOI: 10.1615/JEnvironPatholToxicolOncol.v29.i2.20     Document Type: Review

References (23)

1. Edlich RF, Fisher AL, Chase ME, Brock CM, Gubler KD, Long WB. Modern concepts in the diagnosis and treatment of vitamin D defi ciency and its clinical consequences. J Environ Pathol Toxicol Oncol. 2009;28(1):1-4.
2. Scwartz GG, Wang MH, Zang M, Singh RK, Siegal GP. 1 alpha, 25-dihydroxyvitamin D (calcitriol) inhibits the invasiveness of human prostate cancer cells. Cancer Epidemiol Biomarkers Prev. 1997;6(9):727-32.
3. Lipkin M, Newmark HL. Vitamin D, calcium and prevention of breast cancer: a review. J Am Coll Nutr. 1999;18(5 suppl):392S-397S. (Pubitemid 29455710)
4. Guyton KZ, Kensler TW, Posner GH. Cancer chemoprevention using natural vitamin D and synthetic analogs. Annu Rev Pharmacol Toxicol. 2007;41:421-42.
5. Hansen CM, Binderup L, Hamberg KJ, Carlberg. Vitamin D and cancer: effects of 1,25(OH)2D3 and its analogs on growth control and tumorgenesis. Front Biosci. 2001;6:D820-48.
6. Gorham E, Garland C, Garland F. Acid haze air pollution and breast and colon cancer in 20 Canadian cities. Can J Public Health. 1989;80:96-100.
7. Garland F, Garland C, Gorham E, Young J Jr. Geographic variation in breast cancer mortality in the United States: a hypothesis involving solar radiation. Prev Med. 1990;19:614-22.
8. Garland C, Garland F. Do sunlight and vitamin D reduce the likelihood of colon cancer? Int J Epidemiol. 1989;80:96-100.
9. Lefkowitz ES, Garland CF. Sunlight, vitamin D, and ovarian cancer mortality rates in US women. Int J Epidemiol. 1994 Dec;23(6):1133-6.
10. Schwartz GG, Hulka BS. Is vitamin D defi ciency a risk factor for prostate cancer? (hypothesis). Anticancer Res. 1990;10(5A):1307-11.
11. Hosgood DH, Baris D, Zahm SH, Zheng T, Cross AJ. Diet and risk of multiple myeloma in Connecticut women. Cancer Causes Control. 2007;18(10): 1065-76.
12. Binkley N, Krueger D, Cowgill CS, Plum L, Lake E, Hansen KE, DeLuca HF, Drezner MK. Assay variation confounds the diagnosis of hypovitaminosis D: a call for standardization. J Clin Endocrinol Metab. 2004;89(7):3152-7.
13. Vieth R. Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety. Am J Clin Nutr. 1999;69(5):842-56.
14. Ersfeld DL, Rao DS, Body JJ, Sackrison JL Jr, Miller AB, Parikh N, Eskridge TL, Polinske A, Olson GT, MacFarlane GD. Analytical and clinical validation of the 25 OH vitamin D assay for the LIAISON automated analyzer. Clin Biochem. 2004;37(10):867-74.
15. Hollis BW. Circulating 25-hydroxyvitamin D levels indicative of vitamin D suffi ciency: implications for establishing a new effective dietary intake recommendation for vitamin D. J Nutr. 2005;135(2):317-22.
16. DiaSorin Package Insert; LIASION 25 OH Vitamin D Total Assay (310600); October 2007.
17. Maunsell Z, Wright DJ, Rainbow SJ. Routine isotope-dilution liquid chromatography-tandem mass spectrometry assay for simultaneous measurement of the 25-hydroxy metabolites of vitamins D2 and D3. Clin Chem. 2005 Sep;51(9):1683-90.
18. Tsugawa N, Suhara Y, Kamao M, Okano T. Determination of 25-hydroxyvitamin D in human plasma using high-performance liquid chromatography-tandem mass spectrometry. Anal Chem. 2005;1;77(9):3001-7. (Pubitemid 40617353)
19. Jones G, Horst R, Carter G, Makin HL. Contemporary diagnosis and treatment of vitamin D-related disorders. J Bone Miner Res. 2007 Dec;22 Suppl 2: V11-5.
20. Hollis BW, Kamerud JQ, Selvaag SR, Lorenz JF, Napoli JL. Determination of vitamin D status by radioimmunoassay with and 125I-labled tracer. Clin Chem. 1993;39(3):529-33.
21. Kimball SM, Vieth R. A comparison of automated methods for the quantitation of serum 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D. Clin Biochem. 2007;40(16-17):1305-10.
22. Souberbielle JC, Fayol V, Sault C, Lawson-Body E, Kahan A, Cormier C. Assay-specific decision limits for two new automated parathyroid hormone and 25-hydroxyvitamin D assays. Clin Chem. 2005;51(2):395-400.
23. Glendenning P. Issues of standardization and assay- specific clinical decision limits for the measurement of 25-hydroxyvitamin D. Am J Clin Nutr. 2003;77:521-3.